Stock Name Closing Price on the 19th vs. the previous day.
M&A Soken <9552> 3730-165 Astellas Pharma <4503> 1642-55 Tohoku Electric Power <9506> 1350.5-44 Tokyo Electric Power HD <9501> 796.6-24.3 JVC Kenwood <6632> 909-16 Next Stage <3186> 2029-61 Sumitomo Metal Mining <5713> 4920-159 Japan Post <6178> 1602.5-52 Liberta <4935> 1338+300 SIG Group <4386> 765+100 Metaps <3350> 145+20 Shinto HD <2776> 153-29 SE H&I <9478> 278-21 Tamani <6181> 130+5 Wolves <194A>1149+150 Lacoria Pharmaceutical <4579> 640+2 Sell in the US received a patent evaluation on the 18th and led to buying but lost momentum on the 19th. The selling side is dominant on the 19th.
On the 19th, there was a soft headwind for small to medium growth stocks.
Astellas Pharma <4503> 1642-55
Jefferies Securities downgraded their investment rating.
Tohoku Electric Power <9506> 1350.5-44
On the 18th, there was a strong shift in funds to electrical utility stocks.
Tokyo Electric Power HD <9501> 796.6-24.3
The electrical utility stocks that rose on the 18th turned completely to falling.
JVC Kenwood <6632> 909-16
Be wary of selling pressure at the ¥950 level.
Next Stage <3186> 2029-61
Some weekly magazines view online articles in a negative light.
Sumitomo Metal Mining <5713> 4920-159
The drop in resource prices, including copper prices, is viewed negatively.
Japan Post <6178> 1602.5-52
Daiwa Securities maintains an investment rating of "3".
Lear <4935> 1338+300
Continuing to ride the wave of strong sales of the ice strike wear brand.
SIG Group <4386> 765+100
Continued business partnership with AI start-up companies is seen as a material.
Lannett Co Inc <3350> 145+20
The policy of reapplying for approval of a neuralgia pain treatment after herpes zoster is still ongoing.
Shinto HD <2776> 153-29
Y.S.D.'s shareholding ratio is expected to decline.
SE H&I <9478> 278-21
Performance forecast is revised downward due to cost increase.
Telus <6181> 130+5
Expectations for higher prices are increasing as the 25-day line recovers.
Veru Inc <194A> 1149+150
A joint research agreement related to early detection of cancer.
Lacoria Pharmaceutical <4579> 640+2
Buy in the US received a patent evaluation on the 18th, but lost momentum. The selling side is dominant on the 19th.
Flares (7062) 1660 +168.
Exceeding the year-to-date high set on July 1st, expectations for a rise are rising.
Shinbio Pharmaceuticals (4582) 370-80.
Profit-taking selling is dominant until the 18th surge.
Livomic (4591) 95 +3.
Selling is dominant today despite buying ahead by driving momentum from the previous day's stop.
Noir Immun (4893) 257-55.
After buying out the momentum of the 18th stop, it slowed down.
Headwaters (4011) 11240-70.
Selling is dominant despite supporting the introduction of visual recognition solutions to 500 domestic convenience stores.
Kayak (3904) 670 +7.
Buying precedents for the subsidiary of PR marketing company, but the upper limit is heavy.
Secure Veil (3042) 336 +10.
It gained popularity on the 18th by starting a firewall diagnosis service, etc. On the 19th, sale exceeded buy.
Firewall diagnosis service started etc. Popular on the 18th. Sale exceeds buy on the 19th.